Cytosorbents Corp — Director's Dealing 2017

Jun 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2017-06-08

Reporting Person: Jones Edward Raymond (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-08	Common Stock	P	500	$3.975	Acquired	500	Direct
2017-06-08	Common Stock	P	2000	$3.9995	Acquired	68500	Direct

Footnotes

F1: Includes (i) the following restricted stock units ("RSUs") that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 6,000 RSUs granted on February 24, 2017, (b) 5,000 RSUs granted on June 7, 2016, and (c) 55,000 RSUs granted on April 8, 2015, and (ii) 2,500 shares of common stock purchased by the reporting person in the open market and reported on this Form 4.